Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 – ...
but doctors sometimes prescribe other drugs off label to help them sleep. She called the results of the new study “alarming, but not surprising.” The F.D.A. said the results of the study “will be ...